Evaluation of sample pooling for screening of SARS CoV-2.
Andargachew MuluDawit Hailu AlemayehuFekadu AlemuDessalegn Abeje TeferaSinknesh WoldeGebeyehu Assefa MitikuTamrayehu SeyoumMeseret HabtamuAlemseged AbdissaAbebe Genetu BayihGetachew Tesfaye BeyenePublished in: PloS one (2021)
The approaches showed its concept in easily customized and resource-saving manner and would allow expanding of current screening capacities and enable the expansion of detection in the community. We recommend clinical sample pooling of 4 or 5 in 1. However, we don't advise pooling of clinical samples when disease prevalence is greater than 7%; particularly when sample size is large.